Faruqi and Faruqui, LLP Logo
Share this page

In re Solodyn Antitrust Litig., No. 14-10438 (D. Mass.)


In the Solodyn case, Faruqi & Faruqi represents a pharmaceutical wholesaler and a proposed class of direct purchasers of Medicis’s minocycline drug, Solodyn.  The case alleges that Medicis engaged in an anticompetitive scheme to prevent lower-priced generic competition from entering the market.  The scheme included product reformulations to prevent pharmacists from substituting less-expensive generic versions of Solodyn, and pay-for-delay conspiracies between Medicis and would-be generic competitors. The case settled for $75 million in early 2018.

Contact Counsel

Peter Kohn
Joseph T. Lukens
Neill W. Clark
Faruqi & Faruqi, LLP
1617 JFK Boulevard, Suite 1550
Philadelphia, PA 19103
Tel: (215) 277-5770


Case Details


  • 07/23/2013

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.